In order to address the role of tumour-derived IL-1B signalling in an immune-competent syngeneic model, we orthotopically injected IL1R1-overexpressing E0771 (Supplementary Fig. 2B, D) mouse mammary tumour cells in IL1R1fl/fl and IL1R1−/− mice. This evidence concerns the gene IL1R1 and breast cancer.